Table 3.
Natural Killer Cell Based Therapy
| Clinical Trial Identifier | Phase | Interventions | Status |
|---|---|---|---|
| NCT04324996 | Phase 1/Phase 2 | NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells | Recruiting |
| NCT04634370 | Phase 1 | Natural Killer Cells infusion | Not yet recruiting |
| NCT04280224 | Phase 1 | NK Cell | Recruiting |
| NCT04365101 | Phase1/Phase 2 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 | Active, not recruiting |
| NCT04578210 | Phase1/Phase 2 | Biological: T memory cells and NK cells | Recruiting |
| NCT04344548 | Phase1/Phase 2 | Allogeneic NK transfer | Withdrawn |
| NCT04900454 | Phase 1 | DVX201 | Recruiting |